Charlotte L Metzler, MD | |
4407 Fairmount Ave, Port Angeles, WA 98363-9514 | |
(360) 457-0760 | |
(360) 457-0920 |
Full Name | Charlotte L Metzler |
---|---|
Gender | Female |
Speciality | Dermatology |
Location | 4407 Fairmount Ave, Port Angeles, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548253198 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | MD00027749 (Washington) | Primary |
207NS0135X | Dermatology - Procedural Dermatology | MD00027749 (Washington) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Charlotte L Metzler, MD 4407 Fairmount Ave, Port Angeles, WA 98363-9514 Ph: (360) 457-0760 | Charlotte L Metzler, MD 4407 Fairmount Ave, Port Angeles, WA 98363-9514 Ph: (360) 457-0760 |
News Archive
The study, initiated by the Swiss researchers and published in Nature, constitutes ground-breaking work in exploring emotions in the brain.
In conjunction with Better Speech and Hearing Month, Sonus, a national strategic partner of the American Diabetes Association, has launched a PSA initiative to inform individuals of the link between hearing loss and diabetes. The connection stems from solid research including a study published in the Annals of Internal Medicine, stating hearing loss is about twice as common in adults with diabetes compared to those who do not have the disease.
AMPAC Fine Chemicals LLC (AFC), a subsidiary of American Pacific Corporation (Nasdaq: APFC) announced today that it received the Environmental Responsibility and Sustainability Award at the Annual Statewide Environmental Summit, sponsored by the California Manufacturers and Technology Association (CMTA), the Industrial Environmental Association (IEA) and the Chemical Industry Council of California (CICC) held in San Diego.
Paris is hosting the European Society of Cardiology Congress (ESC) meet this year where on the 2nd of September researchers from the Cleveland Clinic reveal that weight loss surgeries in patients with obesity and type 2 diabetes could reduce the risk death and major untoward heart or cardiovascular events or major adverse cardiovascular events (MACE).
› Verified 2 days ago